Table 2.
Characteristics of cases treated and not treated with total skin electron beam therapy
| TSEBT | Non-TSEBT | |
|---|---|---|
| Number of cases | 13 | 30 |
| Age, years | 60 | 56.9 |
| Range | 38–75 | 12–85 |
| CTCL type | Total (%) | Total (%) |
| MF | 7 | 17 |
| Transformed MF | 2 | 1 |
| CD4+CD8+ | 2 | 6 |
| Unknown | 2 | 0 |
| Sézary syndrome | 0 | 2 |
| CD4−CD8− | 1 | 0 |
| Length of time for oral CTCL to present from initial cutaneous lesions | ||
| Mean in years | 5.4 | 7.3 |
| Range (months to years) | 2–15 | 6–20 |
| Outcome | Total (%) | Total (%) |
| Death | 6 (43) | 13 (57) |
| Alive | 8 (57) | 10 (43) |
| Causes of death | Total (%) | Total (%) |
| Advanced disease | 3 (60) | 4 (40) |
| Sepsis | 1 (20) | 5 (50) |
| Other | 1 (20) | 1 (10) |
| Length of time from initial oral lesion to death | ||
| Mean in months (range) | 10.3 (4–30) | 10.5 (0.5–39) |
TSEBT, total skin electron beam therapy.